Market Research Logo

Global Biosimilar Monoclonal Antibodies Sales Market Report 2018

Global Biosimilar Monoclonal Antibodies Sales Market Report 2018

This report studies the Biosimilar Monoclonal Antibodies market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Biosimilar Monoclonal Antibodies market by product type and applications.

In the last several years, global market of Biosimilar Monoclonal Antibodies developed rapidly, with an average growth rate of 32.6%. In 2017, global revenue of Biosimilar Monoclonal Antibodies is nearly 1500 M USD; the actual production is about 4.05 M Units.

Patent expirations on essential biological drugs is expected to create wider scope for potential opportunities for key players in the biosimilar monoclonal antibodies market in the near future.

However, lack of appropriate standards, stringent government regulations in developed countries, and high research and development costs for development of biosimilar monoclonal antibodies are some major factors restraining growth of the global biosimilar monoclonal antibodies market.

The major players in global Biosimilar Monoclonal Antibodies market include
Celltrion
Pfizer (Hospira)
3SBIO
Novartis (Sandoz)
Dr Reddy¡¯s
Celgen Biopharma
Cadila Healthcare
Hisun Pharma
Torrent Pharmaceuticals

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Biosimilar Monoclonal Antibodies in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
South Korea
India
Rest of World

On the basis of product, the Biosimilar Monoclonal Antibodies market is primarily split into
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other

On the basis on the end users/applications, this report covers
Oncology
Autoimmune Disease
Other


1 Biosimilar Monoclonal Antibodies Market Overview
1.1 Product Overview and Scope of Biosimilar Monoclonal Antibodies
1.2 Classification of Biosimilar Monoclonal Antibodies by Product Category
1.2.1 Global Biosimilar Monoclonal Antibodies Revenue and Growth Comparison by Types (2013-2025)
1.2.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Types in 2017
1.2.3 Infliximab
1.2.4 Rituximab
1.2.5 Trastuzumab
1.2.6 Adalimumab
1.3 Global Biosimilar Monoclonal Antibodies Market by Applications/End Users
1.3.1 Global Biosimilar Monoclonal Antibodies Sales Comparison by Applications (2013-2025)
1.3.2 Global Biosimilar Monoclonal Antibodies Sales Market Share by Applications
1.4 Global Biosimilar Monoclonal Antibodies Market by Regions
1.4.1 Global Biosimilar Monoclonal Antibodies Revenue Comparison by Regions (2013-2025)
1.4.2 United States Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
1.4.3 China Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
1.4.4 Europe Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
1.4.5 South Korea Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
1.4.6 Row Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
1.4.7 India Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
1.5 Global Biosimilar Monoclonal Antibodies Sales and Revenue (2013-2025)
1.5.1 Global Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2025)
1.5.2 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2025)
2 Global Biosimilar Monoclonal Antibodies Competition by Players, Type and Application
2.1 Global Biosimilar Monoclonal Antibodies Market Competition by Players
2.1.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share of Key Players (2017-2018)
2.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Share by Players (2017-2018)
2.2 Global Biosimilar Monoclonal Antibodies Sales and Revenue by Type
2.2.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2013-2018)
2.2.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2013-2018)
2.3 Global Biosimilar Monoclonal Antibodies Sales and Revenue by Regions
2.3.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Regions (2013-2018)
2.3.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Regions (2013-2018)
2.4 Global Biosimilar Monoclonal Antibodies Sales by Application
3 United States Biosimilar Monoclonal Antibodies (Sales, Revenue and Price)
3.1 United States Biosimilar Monoclonal Antibodies Sales and Revenue (2013-2018)
3.1.1 United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
3.1.2 United States Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
3.1.3 United States Biosimilar Monoclonal Antibodies Price Trend (2013-2018)
3.2 United States Biosimilar Monoclonal Antibodies Sales and Market Share by Players
3.3 United States Biosimilar Monoclonal Antibodies Sales and Market Share by Type
3.4 United States Biosimilar Monoclonal Antibodies Sales and Market Share by Applications
4 China Biosimilar Monoclonal Antibodies (Sales, Revenue and Price)
4.1 China Biosimilar Monoclonal Antibodies Sales and Revenue (2013-2018)
4.1.1 China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
4.1.2 China Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
4.1.3 China Biosimilar Monoclonal Antibodies Price Trend (2013-2018)
4.2 China Biosimilar Monoclonal Antibodies Sales and Market Share by Players
4.3 China Biosimilar Monoclonal Antibodies Sales and Market Share by Type
4.4 China Biosimilar Monoclonal Antibodies Sales and Market Share by Applications
5 Europe Biosimilar Monoclonal Antibodies (Sales, Revenue and Price)
5.1 Europe Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
5.1.1 Europe Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5.1.2 Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
5.1.3 Europe Biosimilar Monoclonal Antibodies Price Trend (2013-2018)
5.2 Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Players
5.3 Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Type
5.4 Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Applications
6 South Korea Biosimilar Monoclonal Antibodies (Sales, Revenue and Price)
6.1 South Korea Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
6.1.1 South Korea Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.1.2 South Korea Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
6.1.3 South Korea Biosimilar Monoclonal Antibodies Price Trend (2013-2018)
6.2 South Korea Biosimilar Monoclonal Antibodies Sales and Market Share by Players
6.3 South Korea Biosimilar Monoclonal Antibodies Sales and Market Share by Type
6.4 South Korea Biosimilar Monoclonal Antibodies Sales and Market Share by Applications
7 India Biosimilar Monoclonal Antibodies (Sales, Revenue and Price)
7.1 India Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
7.1.1 India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.1.2 India Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
7.1.3 India Biosimilar Monoclonal Antibodies Price Trend (2013-2018)
7.2 India Biosimilar Monoclonal Antibodies Sales and Market Share by Players
7.3 India Biosimilar Monoclonal Antibodies Sales and Market Share by Type
7.4 India Biosimilar Monoclonal Antibodies Sales and Market Share by Applications
8 Row Biosimilar Monoclonal Antibodies (Sales, Revenue and Price)
8.1 Row Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
8.1.1 Row Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8.1.2 Row Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
8.1.3 Row Biosimilar Monoclonal Antibodies Price Trend (2013-2018)
8.2 Row Biosimilar Monoclonal Antibodies Sales and Market Share by Players
8.3 Row Biosimilar Monoclonal Antibodies Sales and Market Share by Type
8.4 Row Biosimilar Monoclonal Antibodies Sales and Market Share by Applications
9 Analysis of Biosimilar Monoclonal Antibodies Industry Key Manufacturers
9.1 Celltrion
9.1.1 Company Profile
9.1.2 Product Information
9.1.3 Sales, Price, Cost, Gross, and Revenue
9.2 Pfizer (Hospira)
9.2.1 Company Profile
9.2.2 Product Information
9.2.3 Sales, Price, Cost, Gross, and Revenue
9.3 3SBIO
9.3.1 Company Profile
9.3.2 Product Information
9.3.3 Sales, Price, Cost, Gross, and Revenue
9.4 Novartis (Sandoz)
9.4.1 Company Profile
9.4.2 Product Information
9.4.3 Sales, Price, Cost, Gross, and Revenue
9.5 Dr Reddy¡¯s
9.5.1 Company Profile
9.5.2 Product Information
9.5.3 Sales, Price, Cost, Gross, and Revenue
9.6 Celgen Biopharma
9.6.1 Company Profile
9.6.2 Product Information
9.6.3 Sales, Price, Cost, Gross, and Revenue
9.7 Cadila Healthcare
9.7.1 Company Profile
9.7.2 Product Information
9.7.3 Sales, Price, Cost, Gross, and Revenue
9.8 Hisun Pharma
9.8.1 Company Profile
9.8.2 Product Information
9.8.3 Sales, Price, Cost, Gross, and Revenue
9.9 Torrent Pharmaceuticals
9.9.1 Company Profile
9.9.2 Product Information
9.9.3 Sales, Price, Cost, Gross, and Revenue
10 Biosimilar Monoclonal Antibodies Manufacturing Cost Analysis
10.1 Biosimilar Monoclonal Antibodies Key Raw Materials Analysis
10.1.1 Clinical Phase Costs
10.1.2 Capitalized Costs
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Other Costs Analysis
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Biosimilar Monoclonal Antibodies Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Substitutes Threat
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Biosimilar Monoclonal Antibodies Market Forecast (2019-2025)
14.1 Global Biosimilar Monoclonal Antibodies Sales (K Unit), Revenue and Price Forecast (2019-2025)
14.1.1 Global Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2019-2025)
14.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2019-2025)
14.1.3 Global Biosimilar Monoclonal Antibodies Price and Trend Forecast (2019-2025)
14.2 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast by Regions (2019-2025)
14.2.1 Global Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast by Regions (2019-2025)
14.2.2 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast by Regions (2019-2025)
14.2.3 United States Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2019-2025)
14.2.4 Europe Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2019-2025)
14.2.5 China Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2019-2025)
14.2.6 South Korea Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2019-2025)
14.2.7 Row Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2019-2025)
14.2.8 India Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2019-2025)
14.3 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Price Forecast by Type (2019-2025)
14.3.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2019-2025)
14.3.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Type (2019-2025)
14.4 Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2019-2025)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
16.4 Author List
List of Tables and Figures
Figure Product Picture of Biosimilar Monoclonal Antibodies
Table Global Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate Comparison by Types (2013-2025)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Types in 2017
Figure Infliximab Product Picture
Figure Rituximab Product Picture
Figure Trastuzumab Product Picture
Figure Adalimumab Product Picture
Table Global Biosimilar Monoclonal Antibodies Sales (K Unit) Comparison by Applications (2013-2025)
Figure Global Sales Market Share of Biosimilar Monoclonal Antibodies by Applications in 2017
Table Global Market Biosimilar Monoclonal Antibodies Revenue (M USD) Comparison by Regions 2013-2025
Figure United States Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2025)
Figure China Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2025)
Figure Europe Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2025)
Figure South Korea Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2025)
Figure Row Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2025)
Figure India Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2025)
Figure Global Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate (2013-2025)
Figure Global Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2025)
Table Global Biosimilar Monoclonal Antibodies Sales (K Unit) of Key Players (2017-2018)
Table Global Biosimilar Monoclonal Antibodies Sales Share by Players (2017-2018)
Figure 2017 Global Biosimilar Monoclonal Antibodies Sales Share by Players
Figure 2018 Global Biosimilar Monoclonal Antibodies Sales Share by Players
Table Global Biosimilar Monoclonal Antibodies Revenue (M USD) by Players (2017-2018)
Table Global Biosimilar Monoclonal Antibodies Revenue Share by Players (2017-2018)
Figure 2017 Global Biosimilar Monoclonal Antibodies Revenue Share by Players
Figure 2018 Global Biosimilar Monoclonal Antibodies Revenue Share by Players
Table Global Biosimilar Monoclonal Antibodies Sales (K Unit) by Type (2013-2018)
Table Global Biosimilar Monoclonal Antibodies Sales Share by Type (2013-2018)
Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Type (2013-2018)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2017
Table Global Biosimilar Monoclonal Antibodies Revenue (M USD) and Market Share by Type (2013-2018)
Table Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Type (2013-2018)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type in 2018
Table Global Biosimilar Monoclonal Antibodies Sales (K Unit) and Market Share by Regions (2013-2018)
Table Global Biosimilar Monoclonal Antibodies Sales Share by Regions (2013-2018)
Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Regions (2013-2018)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions in 2017
Table Global Biosimilar Monoclonal Antibodies Revenue (M USD) and Market Share by Regions (2013-2018)
Table Global Biosimilar Monoclonal Antibodies Revenue Share by Regions (2013-2018)
Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Regions (2013-2018)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions in 2017
Table Global Biosimilar Monoclonal Antibodies Sales (K Unit) and Market Share by Application (2013-2018)
Table Global Biosimilar Monoclonal Antibodies Sales Share by Application (2013-2018)
Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Application (2013-2018)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2017
Figure United States Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate (2013-2018)
Figure United States Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2018)
Figure United States Biosimilar Monoclonal Antibodies Price (USD/Unit) Trend (2013-2018)
Table United States Biosimilar Monoclonal Antibodies Sales (K Unit) by Players (2017-2018)
Table United States Biosimilar Monoclonal Antibodies Sales Market Share by Players (2017-2018)
Figure United States Biosimilar Monoclonal Antibodies Sales Market Share by Players in 2017
Table United States Biosimilar Monoclonal Antibodies Sales (K Unit) by Type (2013-2018)
Table United States Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
Figure United States Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2017
Table United States Biosimilar Monoclonal Antibodies Sales (K Unit) by Applications (2013-2018)
Table United States Biosimilar Monoclonal Antibodies Sales Market Share by Applications (2013-2018)
Figure United States Biosimilar Monoclonal Antibodies Sales Market Share by Applications in 2017
Figure China Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate (2013-2018)
Figure China Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2018)
Figure China Biosimilar Monoclonal Antibodies Price (USD/Unit) Trend (2013-2018)
Table China Biosimilar Monoclonal Antibodies Sales (K Unit) by Players (2017-2018)
Table China Biosimilar Monoclonal Antibodies Sales Market Share by Players (2017-2018)
Figure China Biosimilar Monoclonal Antibodies Sales Market Share by Players in 2017
Table China Biosimilar Monoclonal Antibodies Sales (K Unit) by Type (2013-2018)
Table China Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
Figure China Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2017
Table China Biosimilar Monoclonal Antibodies Sales (K Unit) by Applications (2013-2018)
Table China Biosimilar Monoclonal Antibodies Sales Market Share by Applications (2013-2018)
Figure China Biosimilar Monoclonal Antibodies Sales Market Share by Applications in 2017
Figure Europe Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate (2013-2018)
Figure Europe Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2018)
Figure Europe Biosimilar Monoclonal Antibodies Price (USD/Unit) Trend (2013-2018)
Table Europe Biosimilar Monoclonal Antibodies Sales (K Unit) by Players (2017-2018)
Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Players (2017-2018)
Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Players in 2017
Table Europe Biosimilar Monoclonal Antibodies Sales (K Unit) by Type (2013-2018)
Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2017
Table Europe Biosimilar Monoclonal Antibodies Sales (K Unit) by Applications (2013-2018)
Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Applications (2013-2018)
Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Applications in 2017
Figure South Korea Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate (2013-2018)
Figure South Korea Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2018)
Figure South Korea Biosimilar Monoclonal Antibodies Price (USD/Unit) Trend (2013-2018)
Table South Korea Biosimilar Monoclonal Antibodies Sales (K Unit) by Players (2017-2018)
Table South Korea Biosimilar Monoclonal Antibodies Sales Market Share by Players (2017-2018)
Figure South Korea Biosimilar Monoclonal Antibodies Sales Market Share by Players in 2017
Table South Korea Biosimilar Monoclonal Antibodies Sales (K Unit) by Type (2013-2018)
Table South Korea Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
Figure South Korea Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2017
Table South Korea Biosimilar Monoclonal Antibodies Sales (K Unit) by Applications (2013-2018)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report